NGEN
NASDAQ · Pharmaceuticals
Nervgen Pharma Corp
$1.35
+0.03 (+2.27%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+825.2% upside
Low Target
$8.17
Average Target
$12.49
High Target
$18.41
Current Price
$1.35
Current
$1.35
$1.35
Target
$12.49
$12.49
$8.17
$12.49 avg
$18.41
Scenario Analysis
Bear Case
$8.17
505.2%
Low target
Base Case
$12.49
+825.2%
Avg target
Bull Case
$18.41
+1,263.7%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$8.49
-84.1% from high
52-Week Low
$3.20
+-57.8% from low
Target vs 52W High
$12.49
+47.1% vs high
Peer Consensus — Pharmaceuticals